advertisement
Kwon YH 31
Showing records 1 to 25 | Display all abstracts from Kwon YH70275 Management of Pediatric Aphakic Glaucoma With Vitrectomy and Tube Shunts
Elshatory YM
Journal of Pediatric Ophthalmology & Strabismus 2016; 53: 339-343
70836 Multimodal registration of SD-OCT volumes and fundus photographs using histograms of oriented gradients
Miri MS
Biomedical optics express 2016; 7: 5252-5267
70528 Sustained Delivery of Timolol Maleate for Over 90 Days by Subconjunctival Injection
Lavik E
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 642-649
70606 Tank-Binding Kinase 1 (TBK1) Gene and Open-Angle Glaucomas (An American Ophthalmological Society Thesis)
Fingert JH
Transactions of the American Ophthalmological Society 2016; 114: T6
70476 OCULAR HYPERTENSION AFTER INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT
Chin EK
Retina (Philadelphia, Pa.) 2017; 37: 1345-1351
70275 Management of Pediatric Aphakic Glaucoma With Vitrectomy and Tube Shunts
Gauger EH
Journal of Pediatric Ophthalmology & Strabismus 2016; 53: 339-343
70528 Sustained Delivery of Timolol Maleate for Over 90 Days by Subconjunctival Injection
Kuehn MH
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 642-649
70606 Tank-Binding Kinase 1 (TBK1) Gene and Open-Angle Glaucomas (An American Ophthalmological Society Thesis)
Robin AL
Transactions of the American Ophthalmological Society 2016; 114: T6
70836 Multimodal registration of SD-OCT volumes and fundus photographs using histograms of oriented gradients
Abràmoff MD
Biomedical optics express 2016; 7: 5252-5267
70476 OCULAR HYPERTENSION AFTER INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT
Almeida DR
Retina (Philadelphia, Pa.) 2017; 37: 1345-1351
70836 Multimodal registration of SD-OCT volumes and fundus photographs using histograms of oriented gradients
Kwon YH
Biomedical optics express 2016; 7: 5252-5267
70606 Tank-Binding Kinase 1 (TBK1) Gene and Open-Angle Glaucomas (An American Ophthalmological Society Thesis)
Scheetz TE
Transactions of the American Ophthalmological Society 2016; 114: T6
70476 OCULAR HYPERTENSION AFTER INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT
Velez G
Retina (Philadelphia, Pa.) 2017; 37: 1345-1351
70528 Sustained Delivery of Timolol Maleate for Over 90 Days by Subconjunctival Injection
Shoffstall AJ
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 642-649
70275 Management of Pediatric Aphakic Glaucoma With Vitrectomy and Tube Shunts
Kwon YH
Journal of Pediatric Ophthalmology & Strabismus 2016; 53: 339-343
70528 Sustained Delivery of Timolol Maleate for Over 90 Days by Subconjunctival Injection
Atkins K
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 642-649
70606 Tank-Binding Kinase 1 (TBK1) Gene and Open-Angle Glaucomas (An American Ophthalmological Society Thesis)
Kwon YH
Transactions of the American Ophthalmological Society 2016; 114: T6
70476 OCULAR HYPERTENSION AFTER INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT
Xu K
Retina (Philadelphia, Pa.) 2017; 37: 1345-1351
70275 Management of Pediatric Aphakic Glaucoma With Vitrectomy and Tube Shunts
Alward WL
Journal of Pediatric Ophthalmology & Strabismus 2016; 53: 339-343
70836 Multimodal registration of SD-OCT volumes and fundus photographs using histograms of oriented gradients
Garvin MK
Biomedical optics express 2016; 7: 5252-5267
70476 OCULAR HYPERTENSION AFTER INTRAVITREAL DEXAMETHASONE (OZURDEX) SUSTAINED-RELEASE IMPLANT
Peraire M
Retina (Philadelphia, Pa.) 2017; 37: 1345-1351
70528 Sustained Delivery of Timolol Maleate for Over 90 Days by Subconjunctival Injection
Dumitrescu AV
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 642-649
70606 Tank-Binding Kinase 1 (TBK1) Gene and Open-Angle Glaucomas (An American Ophthalmological Society Thesis)
Liebmann JM
Transactions of the American Ophthalmological Society 2016; 114: T6
70275 Management of Pediatric Aphakic Glaucoma With Vitrectomy and Tube Shunts
Boldt HC
Journal of Pediatric Ophthalmology & Strabismus 2016; 53: 339-343
70528 Sustained Delivery of Timolol Maleate for Over 90 Days by Subconjunctival Injection
Kwon YH
Journal of Ocular Pharmacology and Therapeutics 2016; 32: 642-649
